Follow the people · Insider
Lai Wang
Lai Wang files insider transactions with the SEC as a president, global head of r&d of BeOne Medicines (ONC). We hold 4 disclosed purchases and sales filed since 9 June 2021, 3 of them in the last 90 days.
- Files forONC
- Disclosed buys and sells4 in all, 3 in the last 90 days
- Last disclosure25 June 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 6 June 2025 — 23 June 2026President, Global Head of R&D · BeOne Medicines (ONC)28 Form 4 lines · source: SEC Form 4
- Filed 7 June 2021 — 5 March 2025Global Head of R&D · BeiGene (BGNE)45 Form 4 lines · source: SEC Form 4
Everything they disclosed
73 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 1,068 shares of BeOne MedicinesSEC Form 425 June 2026American Depositary Shares · traded 23 June 2026 · filed 25 June 2026
- ▼ sold on the open market 1,169 shares of BeOne MedicinesSEC Form 418 June 2026American Depositary Shares · traded 16 June 2026 · filed 18 June 2026
- was granted 118,625 shares of BeOne MedicinesSEC Form 415 June 2026Ordinary Shares · traded 11 June 2026 · filed 15 June 2026
- ▼ sold on the open market 756 shares of BeOne MedicinesSEC Form 415 June 2026American Depositary Shares · traded 11 June 2026 · filed 15 June 2026
- was granted 229,775 shares of BeOne Medicines (a derivative holding)SEC Form 415 June 2026Share Option (Right to Buy) · traded 11 June 2026 · filed 15 June 2026
- ▼ sold on the open market 1,327 shares of BeOne MedicinesSEC Form 410 June 2026American Depositary Shares · traded 8 June 2026 · filed 10 June 2026
- ▼ sold on the open market 40 shares of BeOne MedicinesSEC Form 410 June 2026American Depositary Shares · traded 8 June 2026 · filed 10 June 2026
- was granted 112,606 shares of BeOne MedicinesSEC Form 410 March 2026Ordinary Shares · traded 6 March 2026 · filed 10 March 2026
- was granted 55,029 shares of BeOne MedicinesSEC Form 410 March 2026Ordinary Shares · traded 6 March 2026 · filed 10 March 2026
- was granted 112,606 shares of BeOne MedicinesSEC Form 410 March 2026Ordinary Shares · traded 6 March 2026 · filed 10 March 2026
- was granted 55,029 shares of BeOne MedicinesSEC Form 410 March 2026Ordinary Shares · traded 6 March 2026 · filed 10 March 2026
- was granted 427,895 shares of BeOne MedicinesSEC Form 45 January 2026Ordinary Shares · traded 31 December 2025 · filed 5 January 2026
- was granted 427,895 shares of BeOne MedicinesSEC Form 45 January 2026Ordinary Shares · traded 31 December 2025 · filed 5 January 2026
- ▼ sold on the open market 5,000 shares of BeOne MedicinesSEC Form 411 September 2025American Depositary Shares · traded 9 September 2025 · filed 11 September 2025
- ▼ sold on the open market 2,949 shares of BeOne MedicinesSEC Form 431 July 2025American Depositary Shares · traded 29 July 2025 · filed 31 July 2025
- ▼ sold on the open market 292 shares of BeOne MedicinesSEC Form 431 July 2025American Depositary Shares · traded 29 July 2025 · filed 31 July 2025
- ▼ sold on the open market 800 shares of BeOne MedicinesSEC Form 431 July 2025American Depositary Shares · traded 29 July 2025 · filed 31 July 2025
- ▼ sold on the open market 259 shares of BeOne MedicinesSEC Form 431 July 2025American Depositary Shares · traded 30 July 2025 · filed 31 July 2025
- ▼ sold on the open market 700 shares of BeOne MedicinesSEC Form 422 July 2025American Depositary Shares · traded 18 July 2025 · filed 22 July 2025
- ▼ sold on the open market 1,028 shares of BeOne MedicinesSEC Form 425 June 2025American Depositary Shares · traded 23 June 2025 · filed 25 June 2025
- ▼ sold on the open market 1,177 shares of BeOne MedicinesSEC Form 418 June 2025American Depositary Shares · traded 16 June 2025 · filed 18 June 2025
- ▼ sold on the open market 470 shares of BeOne MedicinesSEC Form 418 June 2025American Depositary Shares · traded 17 June 2025 · filed 18 June 2025
- was granted 162,565 shares of BeOne Medicines (a derivative holding)SEC Form 412 June 2025Share Option (Right to Buy) · traded 10 June 2025 · filed 12 June 2025
- was granted 86,359 shares of BeOne MedicinesSEC Form 412 June 2025Ordinary Shares · traded 10 June 2025 · filed 12 June 2025
- ▼ sold on the open market 600 shares of BeOne MedicinesSEC Form 410 June 2025American Depositary Shares · traded 6 June 2025 · filed 10 June 2025
- ▼ sold on the open market 202 shares of BeOne MedicinesSEC Form 410 June 2025American Depositary Shares · traded 6 June 2025 · filed 10 June 2025
- ▼ sold on the open market 300 shares of BeOne MedicinesSEC Form 410 June 2025American Depositary Shares · traded 6 June 2025 · filed 10 June 2025
- ▼ sold on the open market 300 shares of BeOne MedicinesSEC Form 410 June 2025American Depositary Shares · traded 6 June 2025 · filed 10 June 2025
- was granted 69,251 shares of BeiGeneSEC Form 47 March 2025Ordinary Shares · traded 5 March 2025 · filed 7 March 2025
- ▼ sold on the open market 1,327 shares of BeiGeneSEC Form 425 February 2025American Depositary Shares · traded 21 February 2025 · filed 25 February 2025
- ▼ sold on the open market 575 shares of BeiGeneSEC Form 425 February 2025American Depositary Shares · traded 21 February 2025 · filed 25 February 2025
- ▼ sold on the open market 479 shares of BeiGeneSEC Form 425 February 2025American Depositary Shares · traded 21 February 2025 · filed 25 February 2025
- ▼ sold on the open market 437 shares of BeiGeneSEC Form 425 February 2025American Depositary Shares · traded 21 February 2025 · filed 25 February 2025
- ▼ sold on the open market 1,782 shares of BeiGeneSEC Form 425 February 2025American Depositary Shares · traded 21 February 2025 · filed 25 February 2025
- ▼ sold on the open market 400 shares of BeiGeneSEC Form 425 February 2025American Depositary Shares · traded 21 February 2025 · filed 25 February 2025
- ▼ sold on the open market 5,000 shares of BeiGeneSEC Form 41 October 2024American Depositary Shares · traded 27 September 2024 · filed 1 October 2024
- ▼ sold on the open market 1,062 shares of BeiGeneSEC Form 426 June 2024American Depositary Shares · traded 24 June 2024 · filed 26 June 2024
- ▼ sold on the open market 2 shares of BeiGeneSEC Form 426 June 2024American Depositary Shares · traded 24 June 2024 · filed 26 June 2024
- ▼ sold on the open market 237 shares of BeiGeneSEC Form 420 June 2024American Depositary Shares · traded 17 June 2024 · filed 20 June 2024
- ▼ sold on the open market 478 shares of BeiGeneSEC Form 420 June 2024American Depositary Shares · traded 17 June 2024 · filed 20 June 2024
- ▼ sold on the open market 485 shares of BeiGeneSEC Form 420 June 2024American Depositary Shares · traded 17 June 2024 · filed 20 June 2024
- ▼ sold on the open market 300 shares of BeiGeneSEC Form 420 June 2024American Depositary Shares · traded 17 June 2024 · filed 20 June 2024
- ▼ sold on the open market 841 shares of BeiGeneSEC Form 420 June 2024American Depositary Shares · traded 18 June 2024 · filed 20 June 2024
- was granted 318,253 shares of BeiGene (a derivative holding)SEC Form 47 June 2024Share Option (Right to Buy) · traded 5 June 2024 · filed 7 June 2024
- was granted 168,935 shares of BeiGeneSEC Form 47 June 2024Ordinary Shares · traded 5 June 2024 · filed 7 June 2024
- ▼ sold on the open market 1,103 shares of BeiGeneSEC Form 427 June 2023American Depositary Shares · traded 26 June 2023 · filed 27 June 2023
- ▼ sold on the open market 5 shares of BeiGeneSEC Form 427 June 2023American Depositary Shares · traded 26 June 2023 · filed 27 June 2023
- was granted 507,234 shares of BeiGene (a derivative holding)SEC Form 420 June 2023Share Option (Right to Buy) · traded 15 June 2023 · filed 20 June 2023
- was granted 133,627 shares of BeiGeneSEC Form 420 June 2023Ordinary Shares · traded 15 June 2023 · filed 20 June 2023
- ▼ sold on the open market 1,325 shares of BeiGeneSEC Form 420 June 2023American Depositary Shares · traded 20 June 2023 · filed 20 June 2023
- ▼ sold on the open market 74 shares of BeiGeneSEC Form 49 June 2023American Depositary Shares · traded 7 June 2023 · filed 9 June 2023
- ▼ sold on the open market 161 shares of BeiGeneSEC Form 49 June 2023American Depositary Shares · traded 7 June 2023 · filed 9 June 2023
- ▼ sold on the open market 111 shares of BeiGeneSEC Form 49 June 2023American Depositary Shares · traded 7 June 2023 · filed 9 June 2023
- ▼ sold on the open market 116 shares of BeiGeneSEC Form 49 June 2023American Depositary Shares · traded 7 June 2023 · filed 9 June 2023
- ▼ sold on the open market 458 shares of BeiGeneSEC Form 428 June 2022American Depositary Shares · traded 27 June 2022 · filed 28 June 2022
- was granted 707,876 shares of BeiGene (a derivative holding)SEC Form 424 June 2022Share Option (Right to Buy) · traded 22 June 2022 · filed 24 June 2022
- was granted 125,255 shares of BeiGeneSEC Form 424 June 2022Ordinary Shares · traded 22 June 2022 · filed 24 June 2022
- ▼ sold on the open market 445 shares of BeiGeneSEC Form 422 June 2022American Depositary Shares · traded 17 June 2022 · filed 22 June 2022
- ▼ sold on the open market 723 shares of BeiGeneSEC Form 422 June 2022American Depositary Shares · traded 21 June 2022 · filed 22 June 2022
- ▼ sold on the open market 660 shares of BeiGeneSEC Form 48 June 2022American Depositary Shares · traded 6 June 2022 · filed 8 June 2022
- exercised options over 233,948 shares of BeiGene (a derivative holding)SEC Form 419 May 2022Share Option (Right to Buy) · traded 17 May 2022 · filed 19 May 2022
- exercised options over 999,999 shares of BeiGene (a derivative holding)SEC Form 419 May 2022Share Option (Right to Buy) · traded 17 May 2022 · filed 19 May 2022
- exercised options over 233,948 shares of BeiGeneSEC Form 419 May 2022Ordinary Shares · traded 17 May 2022 · filed 19 May 2022
- exercised options over 999,999 shares of BeiGeneSEC Form 419 May 2022Ordinary Shares · traded 17 May 2022 · filed 19 May 2022
- gave away 58,188 shares of BeiGeneSEC Form 417 December 2021Ordinary Shares · traded 28 September 2021 · filed 17 December 2021
- gave away 58,188 shares of BeiGeneSEC Form 417 December 2021Ordinary Shares · traded 31 October 2021 · filed 17 December 2021
- gave away 58,188 shares of BeiGeneSEC Form 417 December 2021Ordinary Shares · traded 31 October 2021 · filed 17 December 2021
- was granted an unstated number of shares of BeiGeneSEC Form 417 December 2021RMB Shares · traded 15 December 2021 · filed 17 December 2021
- ▼ sold on the open market 455 shares of BeiGeneSEC Form 430 June 2021American Depositary Shares · traded 28 June 2021 · filed 30 June 2021
- was granted 53,625 shares of BeiGeneSEC Form 421 June 2021Ordinary Shares · traded 16 June 2021 · filed 21 June 2021
- ▼ sold on the open market 802 shares of BeiGeneSEC Form 421 June 2021American Depositary Shares · traded 18 June 2021 · filed 21 June 2021
- was granted 332,527 shares of BeiGene (a derivative holding)SEC Form 421 June 2021Share Option (Right to Buy) · traded 16 June 2021 · filed 21 June 2021
- ▼ sold on the open market 656 shares of BeiGeneSEC Form 49 June 2021American Depositary Shares · traded 7 June 2021 · filed 9 June 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.